Evidence map›Paper›PMID 29312891›Full record

ArticleFrontiers in cellular and infection microbiology2017

Impact of Gentamicin Concentration and Exposure Time on Intracellular

Tiva T VanCleave, Amanda R Pulsifer, Michael G Connor, Jonathan M Warawa, Matthew B Lawrenz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Frontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Metabolic Analysis of Intracellular Pathogenic Bacteria Using NMR.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. A Pharmacodynamic Study of Aminoglycosides against PathogenicPharmaceuticals (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in cellular and infection microbiology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tiva T VanCleaveDepartment of Microbiology and Immunology and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, United States.
Amanda R PulsiferDepartment of Microbiology and Immunology and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, United States.
Michael G ConnorDepartment of Microbiology and Immunology and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, United States.
Jonathan M WarawaDepartment of Microbiology and Immunology and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, United States.
Matthew B LawrenzDepartment of Microbiology and Immunology and Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, United States.
University of Louisville · US

Funding

Elucidating the Biogenesis of the Yersinia pestis Containing VacuoleR21AI119557 · NIAID · UNIVERSITY OF LOUISVILLE · PI LAWRENZ, MATTHEW B · 2016 to 2017
$413k
Identification of host factors required for Yersinia pestis macrophage infectionR21AI097608 · NIAID · UNIVERSITY OF LOUISVILLE · PI LAWRENZ, MATTHEW B · 2013 to 2014
$396k
NIAID NIH HHS R21 AI097608NIAID NIH HHS R21 AI119557
6 · The paper itself

Abstract

The study of intracellular bacterial pathogens in cell culture hinges on inhibiting extracellular growth of the bacteria in cell culture media. Aminoglycosides, like gentamicin, were originally thought to poorly penetrate eukaryotic cells, and thus, while inhibiting extracellular bacteria, these antibiotics had limited effect on inhibiting the growth of intracellular bacteria. This property led to the development of the antibiotic protection assay to study intracellular pathogens

Indexed as

AnimalsAnti-Bacterial AgentsCells, CulturedGentamicinsIntravital MicroscopyMacrophagesMiceMicrobial ViabilityTime FactorsYersinia pestisAnti-Bacterial AgentsGentamicinsantibiotic protection assaygentamicinintracellular survivalmacrophagesYersinia pestis

Identifiers

PMID29312891
PMCPMC5732358
OpenAlexW2772037171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.